PCN70 Cost Effectiveness Analysis of Pembrolizumab in the Treatment of Adults with STAGE III Melanoma and Lymph Node Involvement WHO Have Undergone Complete Resection - the Greek Setting
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.207
https://www.valueinhealthjournal.com/article/S1098-3015(20)32463-3/fulltext
Title :
PCN70 Cost Effectiveness Analysis of Pembrolizumab in the Treatment of Adults with STAGE III Melanoma and Lymph Node Involvement WHO Have Undergone Complete Resection - the Greek Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32463-3&doi=10.1016/j.jval.2020.08.207
First page :
Section Title :
Open access? :
No
Section Order :
10158